PHARMACORP RX INC (PCRX.CA) Stock Balance Sheet
Canada - TSX Venture Exchange - TSX-V:PCRX - CA71714X1050 - Common Stock
0.46 CAD
-0.01 (-2.13%)
| MRQ (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 5.02M | 12.89M | 2.24M | 2.73M | 980.00K | |||
| Receivables | 785.90K | 326.80K | N/A | N/A | N/A | |||
| Inventories | 2.46M | 1.31M | N/A | N/A | N/A | |||
| Other Current Assets | 188.20K | 48.00K | 78.80K | 0.00 | 20.50K | |||
| Total Current Assets | 8.46M | 14.57M | 2.32M | 2.73M | 1.00M | |||
| Non-Current Assets | ||||||||
| PPE Net | 4.23M | 4.02M | N/A | N/A | N/A | |||
| Goodwill | 14.03M | 11.48M | N/A | N/A | N/A | |||
| Intangibles | 7.95M | 5.13M | N/A | N/A | N/A | |||
| Other Non-Current Assets | 5.04M | N/A | N/A | N/A | N/A | |||
| Total Non-Current Assets | 31.25M | 20.63M | 0.00 | 0.00 | 0.00 | |||
| TOTAL ASSETS | 39.71M | 35.21M | 2.32M | 2.73M | 1.00M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 493.20K | 149.40K | N/A | N/A | N/A | |||
| Accounts Payable | 2.84M | 1.54M | 46.20K | 16.50K | 26.30K | |||
| Other Current Liabilities | 11.00K | 10.50K | N/A | N/A | N/A | |||
| Total Current Liabilities | 3.34M | 1.70M | 46.20K | 16.50K | 26.30K | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 3.83M | 803.70K | 0.00 | 0.00 | 0.00 | |||
| Deferred Taxes/Income | 2.33M | 2.14M | N/A | N/A | N/A | |||
| Total Non-Current Liabilities | 6.39M | 3.17M | 0.00 | 0.00 | 0.00 | |||
| TOTAL LIABILITIES | 9.73M | 4.87M | 46.20K | 16.50K | 26.30K | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -2.60M | -2.03M | -1.01M | -542.90K | -25.80K | |||
| Additional Paid In Capital | 879.80K | 674.70K | 488.80K | 516.60K | 0.00 | |||
| Minority Interest | 233.30K | 222.50K | N/A | N/A | N/A | |||
| Common Shares | 31.70M | 31.70M | 2.80M | 2.74M | 1.00M | |||
| Shares Outstanding | 117.30M | 117.30M | 40.28M | 40.00M | 40.00M | |||
| Tangible Book Value per Share | 0.07 | 0.12 | 0.06 | 0.07 | 0.02 | |||
| Total Shareholders' Equity | 29.98M | 30.34M | 2.27M | 2.72M | 974.20K | |||
| TOTAL LIABILITIES AND EQUITY | 39.71M | 35.21M | 2.32M | 2.73M | 1.00M | |||
| Statistics | ||||||||
| Debt/Equity | 0.13 | 0.03 | N/A | N/A | N/A | |||
| Current Ratio | 2.53 | 8.59 | 50.23 | 165.66 | 38.04 | |||
| Return On Assets (ROA) | 0.48% | -2.88% | -20.27% | -18.92% | -2.58% | |||
| Return On Equity (ROE) | 0.63% | -3.34% | -20.68% | -19.03% | -2.65% | |||
All data in CAD , ROIC based on taxRate of 0.28